ANPC News
Archived Headlines
- US IPO Week Ahead: The 2020 US IPO market debuts with a 5-IPO week 01/10/20
- US IPO Week Ahead: Holiday hibernation is on the horizon with just 2 small IPOs this week 12/13/19
- Chinese cancer diagnostics provider AnPac Bio-Medical Science sets terms for $22 million US IPO 11/15/19
- US IPO Weekly Recap: More deals price down in a 3-IPO week 11/01/19
- Chinese cancer diagnostics provider AnPac Bio-Medical Science files for a $22 million US IPO 10/31/19
US IPO Week Ahead: Chinese EVs and US tax software lead a diverse 7 IPO week
Seven IPOs and one SPAC plan to raise $2.1 billion in the week ahead, led by tax software provider Vertex (VERX). A handful of companies could join the IPO calendar in the coming week, including leading mortgage lender Rocket Companies...read more
US IPO Week Ahead: One biotech to close out February
Preclinical biotech Passage Bio (PASG) is the only IPO set to price in the coming week. Passage Bio plans to raise $126 million by offering 7.4 million shares at a price range of $16 to $18. At the midpoint, Passage Bio would command a...read more
US IPO Weekly Recap: One Medical pops 58 percent in 5-IPO week
Five companies entered the public market this past week. The health clinic unicorn One Medical (ONEM) posted a 57.6% gain and was joined by titan of tin foil Reynolds Consumer Products (REYN), Black Diamond Therapeutics (BDTX), Arcutis Biotherapeutics...read more
Chinese diagnostics company AnPac Bio-Medical Science prices US IPO at $12, the low end of the range
AnPac Bio-Medical Science, a Chinese provider of multi-cancer screening tests, raised $16 million by offering 1.3 million ADSs at $12, the low end of the range of $12 to $14. The company originally planned to offer 1.7 million ADSs. Each ADS represents one Class...read more